These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7088380)

  • 21. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex- and age-dependence of platelet aggregation in diabetes mellitus.
    Szénási P; Tóth L; Romics L; Kammerer L
    Acta Med Hung; 1988; 45(1):115-25. PubMed ID: 3412860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus.
    Spohr C; Brøns C; Winther K; Dyerberg J; Vaag A
    Platelets; 2005 Aug; 16(5):301-5. PubMed ID: 16011981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Platelet aggregation in vascular disease: possibilities and limits of Born's method].
    Prencipe M; Antonelli M; Argentino C; De Marinis M
    Boll Soc Ital Biol Sper; 1977 Nov; 53(22):2055-60. PubMed ID: 603711
    [No Abstract]   [Full Text] [Related]  

  • 25. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between platelet aggregation in ischemic heart disease patients and the type of hyperlipoproteinemia].
    Kotsiumbas EM
    Klin Med (Mosk); 1986 Jan; 64(1):72-4. PubMed ID: 3959521
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of sex difference on platelet aggregation using an optical method in healthy subjects.
    Beyan C; Kaptan K; Ifran A; Savaşçi S; Oztürk Y; Okmen B
    Clin Lab Haematol; 2006 Feb; 28(1):14-6. PubMed ID: 16430454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
    Ozdener F; Gülbas Z; Erol K; Ozdemir V
    Methods Find Exp Clin Pharmacol; 2005; 27(6):395-400. PubMed ID: 16179957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of a hypolipemic drug (procetofene) on platelet functions and lipid composition in type II B hyperlipoproteinemia.
    Renaud S; Morazain R; Sauvanet JP; Dumont E; Drouin P
    Haemostasis; 1979; 8(2):82-95. PubMed ID: 499929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].
    Ceska R; Stulc T
    Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H; Merk W; Falkner C; Hiller E
    Thromb Res; 1986 Feb; 41(3):281-9. PubMed ID: 3705010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
    Honorato Pérez J; Azanza Perea JR
    Rev Med Univ Navarra; 1982 Mar; 26(1):51-4. PubMed ID: 7111953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behaviour of platelet adhesiveness and of dilute clot blood lysis time in hyperlipoproteinemic subjects.
    Zdrenghea D; Stef C; Cucuianu M; Vlaicu R
    Med Interne; 1979; 17(3):273-7. PubMed ID: 504931
    [No Abstract]   [Full Text] [Related]  

  • 37. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet aggregation and lipid profile in offsprings of young ischemics.
    Khalil A; Kumar D; Venkatesan M
    Indian Pediatr; 1997 Jan; 34(1):16-9. PubMed ID: 9251275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the hemostatic system in young persons with primary hyperlipoproteinemia and after myocardial infarction. IV. Description of various parameters of the blood coagulation system, fibrinolysis and platelet aggregation using regression analysis].
    Borodin M; Chełstowski K; Torbus-Lisiecka B; Gregorczyk J
    Przegl Lek; 1986; 43(11):698-702. PubMed ID: 3575771
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.